Gene Salkind

Dr. Gene Z.
Salkind, MD, is an Independent Director at Upexi, Inc., a Chairman at Mobiquity Technologies, Inc., an Independent Director at Avenir Wellness Solutions, Inc., a Chief of Neurosurgery at Holy Redeemer Health System, a President at Bruno & Salkind Mds and a Professor at Lewis Katz School of Medicine.
He is on the Board of Directors at Upexi, Inc., CURE Pharmaceutical Corp., Avenir Wellness Solutions, Inc., Grove Holdings, Inc., Calico Capital Management LLC and Temple University School of Medicine.
Dr. Salkind was previously employed as an Independent Director by Coeptis Therapeutics Holdings, Inc., a Chief of Neurosurgery by Albert Einstein Medical Center, a Chief of Neurosurgery by Jeanes Hospital, a Chief Resident by The Hospital of The University of Pennsylvania, a Professor by Allegheny Health, Education & Research Foundation, and a Professor by University of Pennsylvania.
He also served on the board at DermTech Operations, Inc. and DermTech, Inc. He received his undergraduate degree from the University of Pennsylvania and a doctorate degree from Lewis Katz School of Medicine.